Literature DB >> 9573245

N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles.

I Gross1, H Hohenberg, C Huckhagel, H G Kräusslich.   

Abstract

Expression of retroviral Gag polyproteins is sufficient for morphogenesis of virus-like particles with a spherical immature protein shell. Proteolytic cleavage of Gag into the matrix (MA), capsid (CA), nucleocapsid (NC), and p6 domains (in the case of human immunodeficiency virus [HIV]) leads to condensation to the mature cone-shaped core. We have analyzed the formation of spherical or cylindrical particles on in vitro assembly of purified HIV proteins or inside Escherichia coli cells. CA protein alone yielded cylindrical particles, while all N-terminal extensions of CA abolished cylinder formation. Spherical particles with heterogeneous diameters or amorphous protein aggregates were observed instead. Extending CA by 5 amino acids was sufficient to convert the assembly phenotype to spherical particles. Sequences C-terminal of CA were not required for sphere formation. Proteolytic cleavage of N-terminally extended CA proteins prior to in vitro assembly led to the formation of cylindrical particles, while proteolysis of in vitro assembly products caused disruption of spheres but not formation of cylinders. In vitro assembly of CA and extended CA proteins in the presence of cyclophilin A (CypA) at a CA-to-CypA molar ratio of 10:1 yielded significantly longer cylinders and heterogeneous spheres, while higher concentrations of CypA completely disrupted particle formation. We conclude that the spherical shape of immature HIV particles is determined by the presence of an N-terminal extension on the CA domain and that core condensation during virion maturation requires the liberation of the N terminus of CA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573245      PMCID: PMC110021          DOI: 10.1128/JVI.72.6.4798-4810.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

Review 1.  Proteolytic processing and particle maturation.

Authors:  V M Vogt
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

Review 2.  Intracellular transport of retroviral capsid components.

Authors:  H G Kräusslich; R Welker
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

Review 3.  RNA packaging.

Authors:  R Berkowitz; J Fisher; S P Goff
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

4.  Crystal structure of dimeric HIV-1 capsid protein.

Authors:  C Momany; L C Kovari; A J Prongay; W Keller; R K Gitti; B M Lee; A E Gorbalenya; L Tong; J McClure; L S Ehrlich; M F Summers; C Carter; M G Rossmann
Journal:  Nat Struct Biol       Date:  1996-09

5.  High-pressure freezing of cell suspensions in cellulose capillary tubes.

Authors:  H Hohenberg; K Mannweiler; M Müller
Journal:  J Microsc       Date:  1994-07       Impact factor: 1.758

6.  Comparative morphology of Gag protein structures produced by mutants of the gag gene of human immunodeficiency virus type 1.

Authors:  D J Hockley; M V Nermut; C Grief; J B Jowett; I M Jones
Journal:  J Gen Virol       Date:  1994-11       Impact factor: 3.891

7.  A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum.

Authors:  M Fäcke; A Janetzko; R L Shoeman; H G Kräusslich
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly.

Authors:  P Spearman; J J Wang; N Vander Heyden; L Ratner
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

9.  Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal.

Authors:  P P Lee; M L Linial
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  The GAG precursor of simian immunodeficiency virus assembles into virus-like particles.

Authors:  M Delchambre; D Gheysen; D Thines; C Thiriart; E Jacobs; E Verdin; M Horth; A Burny; F Bex
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

View more
  88 in total

1.  Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.

Authors:  S Tang; T Murakami; B E Agresta; S Campbell; E O Freed; J G Levin
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Molecular organization of Mason-Pfizer monkey virus capsids assembled from Gag polyprotein in Escherichia coli.

Authors:  Milan V Nermut; Patrick Bron; Daniel Thomas; Michaela Rumlova; Tomas Ruml; Eric Hunter
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  Role of RNA in facilitating Gag/Gag-Pol interaction.

Authors:  Ahmad Khorchid; Rabih Halwani; Mark A Wainberg; Lawrence Kleiman
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Nucleic acid-independent retrovirus assembly can be driven by dimerization.

Authors:  Marc C Johnson; Heather M Scobie; Yu May Ma; Volker M Vogt
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli.

Authors:  S M Joshi; V M Vogt
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Functional surfaces of the human immunodeficiency virus type 1 capsid protein.

Authors:  Uta K von Schwedler; Kirsten M Stray; Jennifer E Garrus; Wesley I Sundquist
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  The dimerization domain of the HIV-1 capsid protein binds a capsid protein-derived peptide: a biophysical characterization.

Authors:  María T Garzón; María C Lidón-Moya; Francisco N Barrera; Alicia Prieto; Javier Gómez; Mauricio G Mateu; José L Neira
Journal:  Protein Sci       Date:  2004-06       Impact factor: 6.725

8.  In vitro assembly of virus-like particles of a gammaretrovirus, the murine leukemia virus XMRV.

Authors:  Romana Hadravová; Alex de Marco; Pavel Ulbrich; Jitka Stokrová; Michal Dolezal; Iva Pichová; Tomás Ruml; John A G Briggs; Michaela Rumlová
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

9.  Structure of the immature retroviral capsid at 8 Å resolution by cryo-electron microscopy.

Authors:  Tanmay A M Bharat; Norman E Davey; Pavel Ulbrich; James D Riches; Alex de Marco; Michaela Rumlova; Carsten Sachse; Tomas Ruml; John A G Briggs
Journal:  Nature       Date:  2012-07-19       Impact factor: 49.962

10.  Non-cleavage site gag mutations in amprenavir-resistant human immunodeficiency virus type 1 (HIV-1) predispose HIV-1 to rapid acquisition of amprenavir resistance but delay development of resistance to other protease inhibitors.

Authors:  Manabu Aoki; David J Venzon; Yasuhiro Koh; Hiromi Aoki-Ogata; Toshikazu Miyakawa; Kazuhisa Yoshimura; Kenji Maeda; Hiroaki Mitsuya
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.